Developer docs
API playgroundTry for free, no card

Search company profiles

Veriton Pharma

Full company profile

uuid000tfxn

Namestring
Veriton Pharma
Legal namestring
Veriton Pharma Limited
Company typeenum
Private
Founded yearint
1997
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWeybridge, United Kingdom
HQ citystring
Weybridge
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
specialty pharmaceuticals, unlicensed medicines, licensed medicines, rare disease drugs, pharmaceutical distribution
Industry2 codes
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAFALAC
Specialty Pharmacies (Complex/High-Cost Therapies)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Specialty Pharmaceuticals
Social media profiles1 record
Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Veriton Pharma supplies both unlicensed and licensed medicinal products to support patient care. Operating as a UK-registered subsidiary brand under SERB Pharmaceuticals, the company provides medicines for the treatment of complex and life-threatening conditions, distributing through established pharmaceutical supply channels used by its parent group.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The source data pertains to SERB Pharmaceuticals, a global specialty pharmaceutical company. Veriton Pharma is mentioned solely as a registered trademark owned by Veriton Pharma Limited, appearing in the footer as a trademark of SERB's parent entity. No specific products, services, or product details for Veriton Pharma are provided in the source content.

Product and service2 records
1Unlicensed medicinal products
CategorySpecialty pharmaceuticals
Description

Unlicensed medicinal products supplied by Veriton Pharma to address patient needs where a fully licensed alternative is not available, supporting healthcare providers in treating complex and life-threatening conditions.

2Licensed medicinal products
CategorySpecialty pharmaceuticals
Description

Licensed medicinal products supplied by Veriton Pharma as part of its specialty pharmaceutical offering, complementing its unlicensed product supply and supporting healthcare providers treating complex and life-threatening conditions.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-headquartered specialty pharmaceutical company focused on access to unlicensed, 'specials' and rare-disease medicines. Directly comparable to Veriton on the niche of supplying both licensed and unlicensed medicines into UK hospital and pharmacy channels.

2Quantum Pharmaceutical (part of Clinigen)
TypeDirect peer
Description

UK specials manufacturer and distributor of unlicensed and licensed medicines to pharmacies and hospitals. Closely comparable to Veriton on the regulated UK unlicensed-medicines supply proposition.

3BCM Specials (BCM Group)
TypeDirect peer
Description

UK-based manufacturer and supplier of unlicensed 'specials' medicines and a range of named-patient and licensed products. Direct peer to Veriton in the UK unlicensed-medicines channel serving pharmacy and hospital customers.

TypeDirect peer
Description

UK pharmaceutical services company specializing in unlicensed medicines, specials manufacturing, and bespoke pharmacy supplies. Overlapping value proposition with Veriton's combined licensed/unlicensed offering.

TypeBroad incumbent
Description

Direct parent of Veriton Pharma; a global specialty pharmaceutical company with antidotes, CBRN countermeasures, and rare-disease medicines across 100+ countries. Comparable as the broader specialty/rare-disease platform that Veriton sits within.

TypeBroad incumbent
Description

Specialty and rare-disease pharmaceutical company operating across Europe and North America. Comparable to Veriton/SERB on the focus on complex, niche specialty therapeutics that require dedicated supply infrastructure.

TypeBroad incumbent
Description

European specialty pharmaceutical company with a dedicated rare-disease business. Comparable to the SERB/Veriton combination on rare-disease and specialty therapeutic orientation.

TypeBroad incumbent
Description

Specialty biopharmaceutical company focused on medical countermeasures, antidotes and CBRN preparedness. Directly comparable to SERB's portfolio and therefore to the emergency-medicine end of Veriton's parent offering.

TypeBroad incumbent
Description

Global specialty pharma group with a significant UK and European off-patent and specialty portfolio. Comparable as a broader incumbent active in UK specialty pharmaceutical supply.

TypeRegional player
Description

European-focused specialty and generics pharmaceutical company with a strong UK hospital-channel presence. Comparable on the model of a private specialty pharma operating across multiple European markets, though with a generics rather than unlicensed-medicines emphasis.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Veriton Pharma

Specialty Pharmaceuticalsveritonpharma.com

Veriton Pharma firmographics

Firmographics
Name
Veriton Pharma
Legal name
Veriton Pharma Limited
Website
https://veritonpharma.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Veriton Pharma industry classification

Industry
Product category
Specialty Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAFALAC
Specialty Pharmacies (Complex/High-Cost Therapies)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

  • Specialty pharmaceuticals
  • Unlicensed medicines
  • Licensed medicines
  • Rare disease drugs
  • Pharmaceutical distribution

Where Veriton Pharma is headquartered

Location

Headquarters

HQ city
Weybridge
HQ country
United Kingdom
HQ region
Europe

Markets served

Veriton Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Veriton Pharma product offering

Product offering

Core offering

Veriton Pharma supplies both unlicensed and licensed medicinal products to support patient care. Operating as a UK-registered subsidiary brand under SERB Pharmaceuticals, the company provides medicines for the treatment of complex and life-threatening conditions, distributing through established pharmaceutical supply channels used by its parent group.

Product overview

The source data pertains to SERB Pharmaceuticals, a global specialty pharmaceutical company. Veriton Pharma is mentioned solely as a registered trademark owned by Veriton Pharma Limited, appearing in the footer as a trademark of SERB's parent entity. No specific products, services, or product details for Veriton Pharma are provided in the source content.

Differentiator

Problem solved

Functional benefit

Products and services

  • Unlicensed medicinal products Unlicensed medicinal products supplied by Veriton Pharma to address patient needs where a fully licensed alternative is not available, supporting healthcare providers in treating complex and life-threatening conditions.
  • Licensed medicinal products Licensed medicinal products supplied by Veriton Pharma as part of its specialty pharmaceutical offering, complementing its unlicensed product supply and supporting healthcare providers treating complex and life-threatening conditions.

Companies that use Veriton Pharma

Customer profile

Ideal customer profiles1 record

Veriton Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Veriton Pharma partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights3 records

Veriton Pharma competitors and assessment

Company assessment

Direct peers

  • Clinigen Group: UK-headquartered specialty pharmaceutical company focused on access to unlicensed, 'specials' and rare-disease medicines. Directly comparable to Veriton on the niche of supplying both licensed and unlicensed medicines into UK hospital and pharmacy channels.
  • Quantum Pharmaceutical (part of Clinigen): UK specials manufacturer and distributor of unlicensed and licensed medicines to pharmacies and hospitals. Closely comparable to Veriton on the regulated UK unlicensed-medicines supply proposition.
  • BCM Specials (BCM Group): UK-based manufacturer and supplier of unlicensed 'specials' medicines and a range of named-patient and licensed products. Direct peer to Veriton in the UK unlicensed-medicines channel serving pharmacy and hospital customers.
  • Mawdsley Brothers: UK pharmaceutical services company specializing in unlicensed medicines, specials manufacturing, and bespoke pharmacy supplies. Overlapping value proposition with Veriton's combined licensed/unlicensed offering.

Broad incumbents

  • SERB Pharmaceuticals: Direct parent of Veriton Pharma; a global specialty pharmaceutical company with antidotes, CBRN countermeasures, and rare-disease medicines across 100+ countries. Comparable as the broader specialty/rare-disease platform that Veriton sits within.
  • Swedish Orphan Biovitrum (Sobi): Specialty and rare-disease pharmaceutical company operating across Europe and North America. Comparable to Veriton/SERB on the focus on complex, niche specialty therapeutics that require dedicated supply infrastructure.
  • Recordati: European specialty pharmaceutical company with a dedicated rare-disease business. Comparable to the SERB/Veriton combination on rare-disease and specialty therapeutic orientation.
  • Emergent BioSolutions: Specialty biopharmaceutical company focused on medical countermeasures, antidotes and CBRN preparedness. Directly comparable to SERB's portfolio and therefore to the emergency-medicine end of Veriton's parent offering.
  • Aspen Pharmacare (UK operations): Global specialty pharma group with a significant UK and European off-patent and specialty portfolio. Comparable as a broader incumbent active in UK specialty pharmaceutical supply.

Regional players

  • Accord Healthcare (Intas Group): European-focused specialty and generics pharmaceutical company with a strong UK hospital-channel presence. Comparable on the model of a private specialty pharma operating across multiple European markets, though with a generics rather than unlicensed-medicines emphasis.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Veriton Pharma social profiles

Digital presence

Veriton Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Veriton Pharma leadership team

Management profile

Number of profiles

Veriton Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Veriton Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veriton Pharma

What does Veriton Pharma do?

Veriton Pharma supplies both unlicensed and licensed medicinal products to support patient care. Operating as a UK-registered subsidiary brand under SERB Pharmaceuticals, the company provides medicines for the treatment of complex and life-threatening conditions, distributing through established pharmaceutical supply channels used by its parent group.

Is Veriton Pharma a public or private company?

Veriton Pharma is a private company. It is classified as corporate owned and is currently operating.

When was Veriton Pharma founded?

Veriton Pharma was founded in 1997. It employs 1 to 10 people.

Where is Veriton Pharma based?

Veriton Pharma is headquartered in Weybridge, United Kingdom, in the Europe region.

Who are Veriton Pharma's main competitors?

Direct peers on record are Clinigen Group, Quantum Pharmaceutical (part of Clinigen), BCM Specials (BCM Group) and Mawdsley Brothers. Broad incumbents are SERB Pharmaceuticals, Swedish Orphan Biovitrum (Sobi), Recordati, Emergent BioSolutions and Aspen Pharmacare (UK operations). Accord Healthcare (Intas Group) is listed as a regional player.

Does Veriton Pharma have an API?

No public API is recorded for Veriton Pharma.

What industry is Veriton Pharma in?

Veriton Pharma's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAFALAC, Specialty Pharmacies (Complex/High-Cost Therapies). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals